Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.Delia Belelli, T.P. Blackburn, J M Balcarek et al.|Molecular Pharmacology|1995Cited by 120
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A. Armstrong, Yogesh Kulathu, Sven M. Lange et al.|PLoS ONE|2021Cited by 96
Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytesDavid L. Downie, Brian Jones, Anthony G. Hope et al.|Neuropharmacology|1994Cited by 50
Characterization of a human 5‐hydroxytryptamine<sub>3</sub> receptor type A (h5‐HT<sub>3</sub>R‐A<sub>S</sub>) subunit stably expressed in HEK 293 cellsAnthony G. Hope, Thomas P. Blackburn, John A. Peters et al.|British Journal of Pharmacology|1996Cited by 46
The interaction of trichloroethanol with murine recombinant 5‐HT<sub>3</sub> receptorsDavid L. Downie, Nicholas M. Barnes, Anthony G. Hope et al.|British Journal of Pharmacology|1995Cited by 44